[Washington, D.C., July 27, 2023] – Viscadia, a leading pharmaceutical forecasting firm, is pleased to announce the appointment of Douglas H. Willson, Ph.D., as Principal.
 
With a career spanning over 20 years, Willson brings extensive experience and expertise in pharmaceutical forecasting, market research, and strategic planning to Viscadia. His appointment reflects Viscadia’s commitment to providing clients with cutting-edge solutions and insights to navigate the complexities of the pharmaceutical landscape. 
 
Willson has held senior leadership positions at distinguished organizations such as Ipsos Healthcare Advisory Services, Cello Health Advantage, ZS Associates, A+A Bell Falla/Bell Falla and Associates, GfK Healthcare, and National Analysts Inc. (now Naxion). Throughout his career, he has led forecasting practices, dri Leveraging ven innovation in market research methodologies, and spearheaded numerous successful forecasting engagements for pharmaceuticals, biologics, medical devices, and diagnostics. 
 
“We are thrilled to welcome Doug to Viscadia,” said Satish K. Kauta, Founder and CEO of Viscadia. “Building on his extensive knowledge, we aim to maintain our commitment to providing gold-standard services and solidifying our position as a premier firm in life sciences forecasting.” 
 
In his role as Principal at Viscadia, Willson will provide strategic guidance, lead forecasting initiatives, and leverage his vast experience to drive innovation and excellence in pharmaceutical forecasting. His appointment reflects Viscadia’s dedication to staying at the forefront of forecasting practices and delivering unparalleled value to clients. 
 
“I am excited to join Viscadia and contribute to their mission of empowering clients with accurate and actionable forecasts,” said Willson. “Viscadia’s commitment to excellence, innovation, and client-centric focus aligns perfectly with my own professional values. I look forward to collaborating with the exceptional team at Viscadia and delivering outstanding forecasting solutions to our clients.” 
 
With the appointment of Douglas H. Willson, Ph.D., Viscadia further enhances its position as a premier provider of forecasting solutions in the life sciences industry. By harnessing the power of advanced analytics, state-of-the-art technologies, and a team of experienced professionals, Viscadia consistently raises the bar in providing precise and actionable forecasts that empower well-informed decision-making. 

Viscadia is a leading boutique forecasting firm specializing in providing innovative and accurate forecasting solutions to the pharmaceutical industry. With a team of industry experts and a commitment to excellence, Viscadia empowers clients to make informed decisions, optimize resource allocation, and achieve business growth. To learn more, visit www.viscadia.com. 
 
Media Contact: 
Jaime Owens 
Senior Marketing Manager  
Viscadia  
jaime.owens@viscadia.com